Home › Cancer (all types) › Missouri
Cancer (all types) clinical trials in Missouri
62 studies for Cancer (all types) are looking for participants at sites in Missouri.
Cities in Missouri
Medically Tailored Meals to Improve Cancer Outcomes
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07924241Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- and 20 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- University of Missouri, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Washington University in St. Louis School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04198766A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- Washington University - Siteman Cancer Center, St Louis
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 5, 2026 · NCT07540572A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Oncology Hematology Associates, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Washington University Medical Campus, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05856981Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Siteman Cancer Center, St Louis
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- The Children's Mercy Hospitals & Clinics ( Site 4024), Kansas City
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 30, 2026 · NCT07630974A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- St. Lukes Hosp. of Kansas City /ID# 259940, Kansas City
- Hulston Cancer Center /ID# 232226, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT04928846A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07094204Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Missouri Cancer Associates, Columbia
- Siteman Cancer Center, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156Collection of Tissue Samples for Cancer Research
- Washington University - St. Louis, St Louis
RecruitingObservational study
2 Months · All sexes · Updated Oct 27, 2026 · NCT00900198Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- Children's Mercy Hospital, Kansas City
Recruiting
Ages 15 to 29 · All sexes · Updated Oct 26, 2026 · NCT05958316A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06835569Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Washington University, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119Galleri® in the Medicare Population.
- Mercy Health - Joplin, Joplin
- Mercy Health - Springfield, Springfield
- Mercy Health St. Louis, St Louis
RecruitingHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Oct 19, 2026 · NCT05673018A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Premier Imaging, Kansas City
- St. Joseph Medical Center, Kansas City
- MidAmerica Cancer Care - American Oncology Partners, Kansas City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT05382559A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05123482An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 to 99 · All sexes · Updated Oct 8, 2026 · NCT07226934FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Renown Regional Medical Center, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT07480356Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
- Siteman Cancer Center ( Site 0153), St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT07600749A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT06997029A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Children's Mercy Hospital ( Site 3024), Kansas City
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 6, 2026 · NCT06941272Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07848841A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07127874uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- University of Missouri, Columbia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- Mercy David C. Pratt Cancer Center, St Louis
RecruitingObservational study
All ages · All sexes · Updated Sep 29, 2026 · NCT01255748Cognitive Rehabilitation Following Breast Cancer Treatment
- University of Missouri, Columbia
Recruiting
Ages 20 to 75 · Women · Updated Sep 22, 2026 · NCT06545045Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- VA St.Louis Healthcare System, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Washington University School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Saint Luke's Cancer Institute, Kansas City
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Siteman Cancer Center at Washington University, St Louis
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Oncology Hematology Associates, Springfield
- Washington University in St. Louis, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06163534Project: Every Child for Younger Patients With Cancer
- University of Missouri Children's Hospital, Columbia
- Children's Mercy Hospitals and Clinics, Kansas City
- Cardinal Glennon Children's Medical Center, St Louis
- and 2 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Children's Mercy Hospital, Kansas City
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Aug 7, 2026 · NCT05999994From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.